These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17716137)

  • 1. Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition.
    Markovsky E; Koroukhov N; Golomb G
    Nanomedicine (Lond); 2007 Aug; 2(4):545-53. PubMed ID: 17716137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
    Cohen-Sela E; Chorny M; Koroukhov N; Danenberg HD; Golomb G
    J Control Release; 2009 Jan; 133(2):90-5. PubMed ID: 18848962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis.
    Cohen-Sela E; Rosenzweig O; Gao J; Epstein H; Gati I; Reich R; Danenberg HD; Golomb G
    J Control Release; 2006 Jun; 113(1):23-30. PubMed ID: 16697068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats.
    Epstein H; Berger V; Levi I; Eisenberg G; Koroukhov N; Gao J; Golomb G
    J Control Release; 2007 Feb; 117(3):322-32. PubMed ID: 17234295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: formulations of mithramycin and bioactivity.
    Cohen-Sela E; Teitlboim S; Chorny M; Koroukhov N; Danenberg HD; Gao J; Golomb G
    J Pharm Sci; 2009 Apr; 98(4):1452-62. PubMed ID: 18704956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.
    Li L; Zhao X; Yang C; Hu H; Qiao M; Chen D
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1170-80. PubMed ID: 21449822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated release.
    Zhu X; Gu J; Wang Y; Li B; Li Y; Zhao W; Shi J
    Chem Commun (Camb); 2014 Aug; 50(63):8779-82. PubMed ID: 24967656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis.
    Sultana S; Talegaonkar S; Ali R; Mittal G; Ahmad FJ; Bhatnagar A
    J Microencapsul; 2012; 29(5):445-54. PubMed ID: 22292965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery.
    Wilson B; Ambika TV; Patel RD; Jenita JL; Priyadarshini SR
    Int J Biol Macromol; 2012 Dec; 51(5):874-8. PubMed ID: 22820011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Route of administration-dependent anti-inflammatory effect of liposomal alendronate.
    Haber E; Afergan E; Epstein H; Gutman D; Koroukhov N; Ben-David M; Schachter M; Golomb G
    J Control Release; 2010 Dec; 148(2):226-33. PubMed ID: 20813142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal alendronate for the treatment of restenosis.
    Gutman D; Golomb G
    J Control Release; 2012 Jul; 161(2):619-27. PubMed ID: 22178594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(vinyl alcohol) physical hydrogel nanoparticles, not polymer solutions, exert inhibition of nitric oxide synthesis in cultured macrophages.
    Andreasen SØ; Chong SF; Wohl BM; Goldie KN; Zelikin AN
    Biomacromolecules; 2013 May; 14(5):1687-95. PubMed ID: 23560438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation.
    Kufleitner J; Worek F; Kreuter J
    J Microencapsul; 2010; 27(7):594-601. PubMed ID: 20923399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel.
    Stinchcombe TE
    Nanomedicine (Lond); 2007 Aug; 2(4):415-23. PubMed ID: 17716129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of albumin-based nanoparticles for the delivery of abacavir.
    Wilson B; Paladugu L; Priyadarshini SR; Jenita JJ
    Int J Biol Macromol; 2015 Nov; 81():763-7. PubMed ID: 26365020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-anisotropic surface coating based on drug immobilized pendant polymer to suppress macrophage adhesion response.
    Kaladhar K; Renz H; Sharma CP
    Colloids Surf B Biointerfaces; 2015 Apr; 128():8-16. PubMed ID: 25723344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
    Subia B; Kundu SC
    Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-based nanoparticles as potential controlled release drug delivery systems.
    Elzoghby AO; Samy WM; Elgindy NA
    J Control Release; 2012 Jan; 157(2):168-82. PubMed ID: 21839127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin micro/nanoparticles entrapping liposomes for itraconazole green formulation.
    de Jesús Valle MJ; Maderuelo Martín C; Zarzuelo Castañeda A; Sánchez Navarro A
    Eur J Pharm Sci; 2017 Aug; 106():159-165. PubMed ID: 28577996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
    Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
    Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.